Intravenous Immune Globulin (IVIG) is an expensive product and is a limited resource. It is prepared by several commercial manufacturers who use plasma derived from donors to produce IVIG.

The BC Provincial Blood Coordinating Office (PBCO) operates an IVIG Utilization Management Program to ensure that enough IVIG is available for patients likely to benefit from the treatment.  The program incorporates the BC Ministry of Health Policy on Health Authority Immune Globulin Utilization Management Directives.  All requests for IVIG use are screened in hospital Transfusion Medicine Services to make sure that IVIG is used in accordance with the BC IVIG Utilization Management Program Guidelines.

For Adult Rheumatology patient IVIG requests, the Transfusion Medicine Services forwards these to the BC Adult Rheumatology IVIG Screening Program.

For Neuromuscular Neurology patients whose conditions are not on the approved IVG Utilization Management Guidelines, these are forwarded to the IVIG Neuromuscular Neurology Screening Program.